Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID06766279

Evaluating Osteopathic Manipulative Treatment to Restore Sense of Smell After COVID-19 Infection

Led by Burrell College of Osteopathic Medicine · Updated on 2025-01-09

32

Participants Needed

1

Research Sites

48 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to determine whether osteopathic manipulative treatment (OMT) can help adults recover their sense of smell after losing it due to COVID-19 infection. Loss of smell is a common symptom of COVID-19 that affects quality of life and safety. The study will also explore how long any improvement in olfactory function lasts. Participants must be adults who tested positive for COVID-19 and currently have some loss of smell. Participants will be randomly assigned to receive either OMT or a sham treatment. The OMT involves occipitoatlantal decompression with specific pressure for 2 minutes and treatment of nasal Chapman points, both performed while lying down. The sham treatment consists of the investigator gently resting their hands on the participant's neck for 5 minutes. Olfactory testing using the "Sniffin' Sticks" method will be done before and after treatment, with follow-up tests daily for up to 10 days to assess changes in smell. Throughout the study, participants will undergo repeated smell tests and evaluations to monitor recovery. The primary outcome is the ability to regain the sense of smell from enrollment until two weeks after treatment. Safety monitoring includes screening for factors that might interfere with treatment or increase risks. The total participation involves initial assessment, treatment, and up to 10 days of follow-up testing to observe lasting effects or natural recovery of smell.

CONDITIONS

Official Title

Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Positive COVID-19 test or diagnosis
  • Self-reported loss or reduction of sense of smell
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Pregnancy
  • Any osteopathic screening findings that increase risk or reduce effectiveness of OA decompression
  • Use of medications that interfere with sense of smell (intranasal zinc, intranasal antihistamines, intranasal corticosteroids)
  • Allergic rhinitis
  • Use of oral corticosteroids or antihistamines

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Burrell College of Osteopathic Medicine

Las Cruces, New Mexico, United States, 88001

Actively Recruiting

Loading map...

Research Team

T

Thomas P Eiting, Ph.D

A

Adrienne Kania, D.O.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Activation of the cholinergic antiinflammatory reflex by occipitoatlantal decompression and transcutaneous auricular vagus nerve stimulation.

Adrienne M Kania, Kailee N Weiler, Angeline P Kurian...

https://pubmed.ncbi.nlm.nih.gov/33694358

'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold.

T Hummel, B Sekinger, S R Wolf...

https://pubmed.ncbi.nlm.nih.gov/9056084

Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss.

Teresa P Nguyen, Zara M Patel

https://pubmed.ncbi.nlm.nih.gov/29901865

Olfactory identification testing as a predictor of the development of Alzheimer's dementia: a systematic review.

Gordon H Sun, Cyrus A Raji, Mark P Maceachern...

https://pubmed.ncbi.nlm.nih.gov/22552846